Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236119
Status:
COMPLETED
Last Update Posted:
2012-08-23
First Post:
2005-10-11
Brief Title:
Study of the Efficacy Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Psoriasis |
Keywords: